Sinovac Biotech Ltd (SVA) — Cash Flow Quality Index
Sinovac Biotech Ltd (SVA) has a Cash Flow Quality Index of 7.92x as of June 2023. Operating cash flow of $578.90 Million exceeds net income of $73.11 Million, indicating high earnings quality where cash backs reported profits. Explore Sinovac Biotech Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sinovac Biotech Ltd Cash Flow Quality Index (2007–2022)
Historical Cash Flow Quality Index for Sinovac Biotech Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SVA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sinovac Biotech Ltd (2007–2022)
Year-by-year earnings quality comparison for Sinovac Biotech Ltd. For live market cap and the full company financial profile, see SVA company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -8.75x | $-770.75 Million | $88.13 Million | ▼ -923.6% |
| 2021 | 1.06x | $15.35 Billion | $14.46 Billion | ▼ -59.0% |
| 2020 | 2.59x | $479.31 Million | $185.18 Million | ▲ +332.0% |
| 2019 | 0.60x | $39.07 Million | $65.22 Million | ▲ +172.4% |
| 2018 | 0.22x | $7.94 Million | $36.11 Million | ▼ -86.5% |
| 2017 | 1.63x | $59.76 Million | $36.70 Million | ▲ +104.5% |
| 2014 | -36.30x | $-10.13 Million | $279.00K | ▼ -7674.6% |
| 2013 | 0.48x | $5.58 Million | $11.64 Million | ▼ -69.9% |
| 2009 | 1.59x | $48.41 Million | $30.41 Million | ▲ +85.1% |
| 2008 | 0.86x | $10.50 Million | $12.22 Million | ▲ +52.4% |
| 2007 | 0.56x | $4.32 Million | $7.65 Million | — |